Targeting LAG-3 Across Tumor Types: Clinical Insights on New Data

Targeting LAG-3 Across Tumor Types: Clinical Insights on New Data is organized by Projects In Knowledge Inc. (PIK).

Release Date: Apr 10, 2023
Termination Date: Apr 09, 2024

Activity Goal:
The goal of this program is to provide clinicians with a resource to help them understand the key principles of immune checkpoint targets to improve and optimize patient outcomes.

Learning Objective(s):
• Evaluate recent clinical data for new and emerging checkpoint-targeting therapeutic approaches.
• Consider appropriate checkpoint-targeting therapeutic regimens for cancer treatment across tumor types.

Additional details will be posted as soon as information is available.

0.5 MOC | 0.5 IPCE | 0.5 AMA PRA Category 1 Credit™ | 0.5 Contact Hours | 0.1 CEU